Mazen Dimachkie
Professor and Director · University of Kansas School of Medicine
Credentials: · · · · · ·
History
- Present
Department of Neurology · University of Kansas School of Medicine
- 1995–1996
Neuromuscular Medicine
- 1994–1995
Clinical Neurophysiology
- 1990–1994
Center
- 1984–1988
Doctor of Medicine
Research
Annals of the Rheumatic Diseases · 2017 · 1,129 citations
Guillain-Barré syndrome and variants
Case report · Neurologic Clinics · 2013 · First of 2 authors · Corresponding · 251 citations
Treatment of Myasthenia Gravis
Review · Neurologic Clinics · 2018 · 176 citations
104 papers
54 papers · 2 as a fellow
- TM
22 papers
- JK
17 papers
- AA
16 papers
- AM
16 papers
15 papers
14 papers · 6 as a fellow
Grants
- 2026–2028
Digital Biomarkers of Motor Function as Drug Development Tools in Charcot-Marie-Tooth Disease
Food and Drug Administration · U01
PI · $1.1M · Biosensics, Llc
- 2015–2022
Phase II Trial of Arimoclomol in IBM
Food and Drug Administration · R01
Contact PI · $1.6M · University of Kansas Medical Center
Clinical trials
- 2025–2026
Oxaloacetate in Myasthenia Gravis
Principal investigator · Withdrawn · Phase 1
University of Kansas Medical Center
- 2025
Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy
Principal investigator · Withdrawn · Phase 2
University of Kansas Medical Center
- 2023–2028
Principal investigator · Active not recruiting
University of Kansas Medical Center
- 2022–2027
Phase III Trial of Sirolimus in IBM
Principal investigator · Active not recruiting · Phase 3
University of Kansas Medical Center